Search PubMed⌕ Search

Biomedical subjects

G Steiner

Publications and source records attributed to G Steiner.

At least 253 records · Page 14Linked to original sources

Epidermal cell-induced generation of cytotoxic T-lymphocyte responses against alloantigens or TNP-modified syngeneic cells: requirement for Ia-positive Langerhans cells.

The role of epidermal cells (EC) in the activation of T-cell proliferation is well established. In this study we asked whether EC can provide a stimulus resulting in the generation of genetically restricted T-cell cytotoxicity. For this purpose, C57Bl/6 or C3H/He highly purified, accessory cell-depleted responder splenic T lymphocytes, were stimulated in 5-day cell-mediated cytotoxicity cultures with mitomycin C-treated allogeneic or trinitrophenyl (TNP)-modified syngeneic EC, or, for control purposes, with unfractionated spleen cells (SC). Untreated and complement (C')-treated EC induced strong cytotoxic T lymphocyte (CTL) activity in highly purified allogeneic T cells and, in analogy, TNP-modified EC led to the generation of TNP-self CTL, as tested in 4-h 51Cr release assays against allogeneic or TNP-modified syngeneic EC or SC targets. These cytotoxic responses were comparable in magnitude to those seen with allogeneic or TNP-modified syngeneic SC stimulators. In contrast, alloreactive or TNP-self CTL responses were not generated when stimulating EC were depleted of Langerhans cells by pretreatment with anti-Ia monoclonal antibodies plus C' or, for control purposes, when highly purified T-cell stimulators were used. These results demonstrate that EC induce the generation of alloreactive and TNP-self CTL in the absence of Ia-positive splenic accessory cells and that Ia-bearing Langerhans cell are required for this process to occur.

Animals↗

Receptor and postreceptor insulin resistance induced by in vivo hyperinsulinemia.

We examined the effects of inducing hyperinsulinemia in vivo in rats on the insulin receptors of, and the glucose oxidation by their adipocytes. Hyperinsulinemia was induced over a 2-week period by injecting NPH insulin subcutaneously. This was given in doses that were gradually increased to a final dose of 6 units/day. Profound hypoglycemia was avoided by providing supplemental sucrose to both the insulin-treated and control rats. The insulin concentration was eight times greater in the insulin-treated rats. However, they were not grossly obese and their adipocytes were not enlarged. The adipocytes of the hyperinsulinemic rats had a 25% lower maximal insulin binding capacity and were resistant to the effects of insulin on glucose oxidation. We felt that the hyperinsulinemia was sufficient so that, despite their somewhat lower insulin binding capacity, these adipocytes would not bind less insulin in vivo than would adipocytes from control rats. Hence, we postulated that, this massive hyperinsulinemia not only down regulated the insulin receptor, but also led to a postreceptor resistance. This notion was supported by two lines of in vitro data. First, even at maximally effective medium concentrations of insulin, the maximum rate of glucose oxidation by the adipocytes from hyperinsulinemic rats reached a plateau which was less than that reached by cells from controls. Second, when this in vitro glucose oxidation was related not merely to the medium insulin concentration, but to the amount of insulin bound to adipocytes, the response of the hyperinsulinemic rats' cells was always lower than control.(ABSTRACT TRUNCATED AT 250 WORDS)

Adipose Tissue↗

Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens.

Giant cell tumors of bone dissociated by collagenase digestion were found to be composed of four different cell types defined by morphology, growth in culture, and pattern of staining with monoclonal antibodies. Giant cells comprised an average of 0.8% of the cells recovered, with the remainder consisting of small stromal cells. Of the giant cells, 20-57% expressed Ia antigens, while all lacked IgG Fc receptors and five differentiation antigens associated with mature members of the monocyte-macrophage lineage (M phi S-1, M phi P-9, M phi P-15, M phi S-39, and 63d3). One antigen, M phi U-50, found on early monocytoid forms was expressed on Ia+ giant cells. 6-36% of the remaining stromal tumor cells formed a second subpopulation that assumed either a rounded or elongated shape in culture. These cells bore Ia antigens, IgG Fc receptors, and five antigens of the monocyte-macrophage lineage usually found on blood monocytes. However, these cells differed from monocytes or macrophages in that the antigen M phi R-17 generally found on tissue macrophages was absent, and the M phi U-50 antigen present on more primitive cells was well expressed. A very limited endocytic capacity was demonstrable. A third population of up to 24% of the tumor cells was defined by the presence of intense staining for Ia antigens but the absence of antigens of mature monocytes. A proportion of these cells expressed M phi U-50 and a minority had IgG Fc receptors. The two Ia(+) populations of stromal cells were not identifiable after 2 wk of culture, nor did tumor cells selected for the presence of Ia antigens proliferate in culture. A fourth population of cells lacked Ia and monocyte lineage antigens, but showed pronounced intracellular staining for acid phosphatase. These cells had a distinctive plump epitheloid to fibroblastoid morphology and were readily established in long-term culture where they gave rise to large multinuclear Ia(-) cells containing acid phosphatase. The possibility is discussed that the cell types of these tumors relate to various stages in the development of osteoclasts from precursors in the mononuclear phagocyte lineage.

Acid Phosphatase↗

The effect of low density lipoprotein on in vitro porcine endothelial cell reendothelialization.

We have studied the effect of low density lipoproteins (LDL) on the ability of porcine thoracic aortic endothelial cells (EC's) to reendothelialize an in vitro experimental wound made in a confluent monolayer culture. Our results show that normolipidemic LDL enhances EC regeneration primarily by acting as a mitogenic agent on the cells in the migrating sheet of cells covering the denuded wound area. There was no evidence of LDL induced cytotoxicity in our study.

Animals↗

[New method of isolating components of immune complexes, using the example of rheumatoid arthritis].

Immune complexes were precipitated under defined conditions using polyethleneglycol. The precipitation was subjected to the first electrophoresis under nondecomposed conditions for immune complexes. In this way IgG can essentially be separated from the immune complexes which remain in the place where they were applied. In a second electrophoresis, the broken immune complexes were fractionated into IgM and IgG bands. These were analysed for antibody activity by means of hemagglutination and immunofluorescent methods. In serum of 20 rheumatoid arthritis patients, we could detect in the IgM fraction of the immune complexes the rheumatoid factor, an antinuclear antibody, and a new unknown antibody directed against cell plasma membranes of human muscle cells and endothelial cells. The importance of this new antibody in the pathogenesis was discussed.

Antigen-Antibody Complex↗

Effect of hormones and 3', 5'-cyclic AMP on very low density lipoprotein receptors.

Human 125I-labelled VLDL interacts with rat adipocytes in vitro, with properties typical of a ligand-receptor interaction. This VLDL-receptor interaction is modulated by hormones which are known to change cyclic AMP levels. Norepinephrine and isoproterenol, both of which elevate cycle AMP, increase the binding of VLDL to adipocytes. Dibutyryl-cyclic AMP, a derivative of cyclic AMP, also increases the VLDL binding to adipocytes. Insulin reverses the catecholamine-induced increase in VLDL binding. This parallels insulin's effect on the catecholamine-induced changes in cyclic AMP. Direct addition of cyclic AMP itself increases VLDL binding to adipocyte membranes, a system in which no lipolysis of new protein synthesis occurs. Based on the competition between unlabelled VLDL and 125I-labelled VLDL, we conclude that catecholamines act on adipocytes, and cyclic AMP on membrane fractions, by increasing their capacity rather than their affinity to bind VLDL.

Adipose Tissue↗

[Cytotoxic complement-dependent anti-thrombocyte antibodies in rheumatoid arthritis patients].

Sera of 38 patients and 10 blood donors were examined for cytotoxicity against human thymocytes. As method for testing the complement-dependent cytotoxicity the lymphocytotoxicity test was adapted for thymocytes. The sera of blood donors and of patients with non-rheumatic diseases showed no or only a very small rate of cytolysis (3.6%). The rate of cytolysis of sera of patients with arthroses (8.5%) and of collagenoses (14.5%) were below 20%, i.e. still within the limits of normal. The sera of seronegative arthritides (30%) and of patients with rheumatoid arthritis (40%) showed an unequivocally pathological cytotoxicity. The complement-dependent thymocytotoxicity might be coordinated to the clinical arthritis.

Arthritis, Rheumatoid↗

The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemia.

The kinetics of VLDL (Sf 60-400) and IDL (Sf 12-60) B apoprotein were examined in five type III hyperlipoproteinemic subjects. The production rates for B apoprotein were significantly greater in the IDL fraction than in VLDL. Precursor-product relationships between VLDL and IDL B apoprotein illustrated that a significant proportion of IDL B apoprotein was derived from some source other than VLDL catabolism. These observations indicated that, in the five individuals studied, an 'unusual' B apoprotein synthetic pathway operated whereby B apoprotein was directly entering the IDL fraction. Furthermore, this second pathway resulted in an overproduction of IDL B apoprotein and possibly was the major defect leading to the development of the type III hyperlipoproteinemia lipid profile. In two subjects who were restudied following hormonal treatment (estrogen or thyroxine replacement) and in whom the type III hyperlipoproteinemia lipid profile no longer existed, it was found that the pathway for direct synthesis of IDL B apoprotein had been abolished. From these studies we have concluded that a pathway for the direct synthesis of IDL B apoprotein operates in type III hyperlipoproteinemics and it is a major causative factor in the development of the IDL accumulation characteristic of this metabolic disorder.

Adult↗

Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential.

This paper reviews and integrates a number of experiments which suggest the existence of a vicious cycle. In this cycle hypertriglyceridemia can lead to insulin resistance even without concomitant obesity or non-insulin dependent diabetes. This insulin resistance may be the basis for the hyperinsulinemia response to a glucose challenge. The hyperinsulinemia can stimulate VLDL-triglyceride production. This increase in production, if it is not accompanied by an equivalent increase in removal, will result in hypertriglyceridemia. The whole cycle would accelerate VLDL-triglyceride turnover and may increase the supply of potentially atherogenic VLDL-remnants.

Animals↗

[New pathogenetic aspects of rheumatoid arthritis].

Inflammatory changes in the epiphyseal bones in patients with rheumatoid arthritis are demonstrated which correspond to changes in the bone organ far from pannus. They may be the cause for the demineralisation near to joint (first x-ray sign to rheumatoid arthritis). Further from the analysis of immune complexes of patients with rheumatoid arthritis apart from rheumatoid and antinuclear factors and IgM-antibody against plasma membranes was the result. These two findings are new in the description of the pathogenesis of rheumatoid arthritis. Their possible importance for the development of the arthrosis is discussed.

Antibodies, Anti-Idiotypic↗

Synthesis and antihypertensive activity of new 6-heteroaryl-3-hydrazinopyridazine derivatives.

The synthesis and pharmacological activity of new 6-heteroaryl-3-hydrazinopyridazines with antihypertensive action are described. The introduction of pyrrole, pyrazole, imidazole, triazole, tetrazole, thiophene, indole, and carbazole heterocyclic rings into the 6 position of the pyridazine nucleus has been carried out by three different methods of synthesis. The hypotensive action has been examined on normotensive and spontaneously hypertensive rats by comparison with dihydralazine (I). 6-Imidazol-1-yl derivatives have proved particularly active. Of these derivatives, 3-hydrazino-6-(2-methylimidazol-1-yl)pyridazine (7c) achieves 4.9 times the activity of dihydralazine when administered orally to spontaneously hypertensive rats. The LD50 values of 7c and dihydralazine are very similar.

Animals↗

Heterogeneity of VLDL triglyceride production by the liver and intestine.

These studies examine the mechanisms responsible for the heterogeneous nature of very low density lipoprotein (VLDL) triglyceride production. The fasting dog has been used as a model to follow the incorporation of [2-3H]glycerol and [1-14C]palmitate into the triglyceride of VLDL isolated from plasma and from mesenteric lymph. The former represents mainly hepatic VLDL, and the latter, intestinal VLDL. VLDL from each source has been subfractionated into Sf 100-400, Sf 60-100, and Sf 20-60 components. The plateau in triglyceride specific activity achieved during constant infusions of the labelled precursors was higher in small VLDL than in large VLDL. This indicates that the small VLDL triglyceride is not derived exclusively from that in large VLDL. This applies to both hepatic and intestinal VLDL. This contrasts with apolipoprotein B in small VLDL, which other studies show to be entirely derived from large VLDL. Thus both the liver and the intestine incorporate triglyceride into particles whose density extends through the entire VLDL spectrum. Unless triglyceride-rich lipoproteins with the density of VLDL but with no apolipoprotein B are produced, these data raise the possibility that triglyceride may enter VLDL directly.

Animals↗